The Patent Finder

Antibodies Binding Axl

Genmab A/S

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application PCT/EP2015/065900, filed Jul 10, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,201,607Antibodies Binding Axl
In force
 · High confidence
Genmab A/SIn force
High confidence
US 10,500,276Antibodies Binding Axl
In force
 · High confidence
Genmab A/SIn force
High confidence
US 10,512,688Antibodies Binding Axl
In force
 · High confidence
Genmab A/SIn force
High confidence
US 10,765,743Antibodies Binding Axl
In force
 · High confidence
Genmab A/SIn force
High confidence
US 12,589,150Antibodies Binding Axl
In force
 · Medium confidence
Genmab A/SIn force
Medium confidence
Application 16/673,383Antibodies Binding Axl
Abandoned
Abandoned Mar 7, 2023
Genmab A/SAbandonedAbandoned Mar 7, 2023
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Genmab A/S.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited